Diagnosis of invasive fungal infections: challenges and recent developments
W Fang, J Wu, M Cheng, X Zhu, M Du, C Chen… - Journal of biomedical …, 2023 - Springer
Background The global burden of invasive fungal infections (IFIs) has shown an upsurge in
recent years due to the higher load of immunocompromised patients suffering from various …
recent years due to the higher load of immunocompromised patients suffering from various …
Diagnosis of severe respiratory infections in immunocompromised patients
E Azoulay, L Russell, A Van de Louw, V Metaxa… - Intensive care …, 2020 - Springer
An increasing number of critically ill patients are immunocompromised. Acute hypoxemic
respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU …
respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU …
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
JA Fishman, H Gans… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …
American Society of Transplantation review the diagnosis, prevention, and management of …
A new age in molecular diagnostics for invasive fungal disease: are we ready?
Invasive fungal diseases (IFDs) present an increasing global burden in
immunocompromised and other seriously ill populations, including those caused by …
immunocompromised and other seriously ill populations, including those caused by …
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches
Pneumocystis jirovecii can cause life-threatening pneumonia in immunocompromised
patients. Traditional diagnostic testing has relied on staining and direct visualization of the …
patients. Traditional diagnostic testing has relied on staining and direct visualization of the …
The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
A Apostolopoulou, JA Fishman - Journal of Fungi, 2022 - mdpi.com
Pneumocystis jiroveci remains an important fungal pathogen in immunocompromised hosts.
The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne …
The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne …
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
MF Di Pasquale, G Sotgiu, A Gramegna… - Clinical Infectious …, 2019 - academic.oup.com
Background The correct management of immunocompromised patients with pneumonia is
debated. We evaluated the prevalence, risk factors, and characteristics of …
debated. We evaluated the prevalence, risk factors, and characteristics of …
Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus
Background Pneumocystis jirovecii pneumonia (PCP) causes substantive morbidity in
immunocompromised patients. The EORTC/MSGERC convened an expert group to …
immunocompromised patients. The EORTC/MSGERC convened an expert group to …
Pneumocystis jirovecii: a review with a focus on prevention and treatment
Introduction: Pneumocystis jirovecii (PJ) is an opportunistic fungal pathogen that can cause
severe pneumonia in immunocompromised hosts. Risk factors for Pneumocystis jirovecii …
severe pneumonia in immunocompromised hosts. Risk factors for Pneumocystis jirovecii …